期刊文献+

Cpd5对人卵巢癌SKOV3细胞增殖抑制和凋亡诱导作用 被引量:2

Proliferation inhibition and apoptosis induction in human ovarian cancer SKOV3 cells by Cpd5
下载PDF
导出
摘要 目的:观察Cpd5[2-(2-巯基乙醇)-3-甲基-1,4-萘醌,Compound5]对人卵巢癌SKOV3细胞增殖和凋亡的影响。方法:MTT法观察Cpd5对SK-OV3细胞的生长抑制作用,AnnexinV/PI双标记流式细胞术检测Cpd5对SKOV3细胞的凋亡诱导,Hoechst-33258染色荧光显微镜观察细胞凋亡形态。结果:5、10、20、30、40、50、60μmol/LCpd5处理SKOV3细胞48h,生长抑制率分别为2.77%、5.19%、10.61%、41.15%、71.37%、82.90%、89.81%。不同时间点(12、24、48和72h)检测,细胞生长抑制率存在剂量-时间依赖关系。流式细胞术检测,30μmol/LCpd5处理12、24和48h后,细胞凋亡率分别达9.25%、20.07%、56.16%;50μmol/L组的细胞凋亡率明显高于30μmol/L,且随时间增加而显著增加。用40、50和60μmol/LCpd5处理细胞12h,光镜观察即可见明显的形态学改变。荧光显微镜观察:AnnexinV-EGFP/PI双染显示,实验组比阴性对照组细胞凋亡率明显增多;Cpd5作用24、48h后,Hoechst-33258染色可见细胞出现明显的凋亡形态,20μmol/L浓度组凋亡率增加,30、40、50、60μmol/L各组细胞凋亡率显著增加。结论:Cpd5能以剂量-时间依赖的方式抑制SKOV3细胞增殖并诱导凋亡,是潜在的抗卵巢癌新化合物。 AIM:To investigate the effect of Cpd5 on the proliferation inhibition and apoptosis induction in human ovarian cancer SKOV3 cells.METHODS:The growth inhibition of Cpd5 in SKOV3 cells was detected by MTT assay.AnnexinV/PI staining was employed for quantifying apoptotic cells by fluorescence microscopy and flow cytometry.The apoptotic morphology was observed by Hoechst-33258 staining.RESULTS:After Cpd5 treatment at the concentrations of 5,10,20,30,40,50 and 60 μmol/L for 48 h,the ratios of the cells growth inhibition were 2.77%,5.19%,10.61%,41.15%,71.37%,82.90% and 89.81%,respectively.The proliferation was inhibited after Cpd5 treatment at different times of 12,24,48 and 72 h,the cells were inhibited by Cpd5,in a dose-time-dependent manner.The apoptotic cells accounted for 9.25%,20.07% and 56.16%,after Cpd5 treatment by 30 μmol/L for 12,24 and 48 h,respectively.The ratio of apoptotic cells in 50 μmol/L group was significantly higher than that in 30 μmol/L group.The morphological changes were emerged after Cpd5 treatment at the concent rations of 40,50 and 60 μmol/L for 12 h.Compared with the control group,the ratios of the apoptotic cells were increased significantly in the groups induced by Cpd5 at different concentrations.The apoptotic cells were increased in the groups of Cpd5 treatment at 20 μmol/L for 24 h and 48 h by Hoechst-33258 staining.Furthermore,the ratios of apoptotic cells were increased significantly in the groups of Cpd5 treatment at 30,40,50 and 60 μmol/L Cpd5 at different time-points.CONCLUSION:Cpd5 can induce proliferation inhibition and apoptosis in SKOV3 cells,in a dose-time-dependent manner.Our data reveal that Cpd5 is a novel anti-ovarian cancer compound.
出处 《中国临床药理学与治疗学》 CAS CSCD 2009年第10期1121-1127,共7页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 山东省卫生厅(2001CA1CFA1) 教育厅科技计划项目(J01K12)
关键词 Cpd5 细胞凋亡 卵巢癌 SKOV3 Cpd5 apoptosis ovarian cancer SKOV3
  • 相关文献

参考文献11

  • 1Osada S, Carr BI. Mechanism of novel vitamin K analog induced growth inhibition in human hepatoma cell line [J]. Hepatol,2001,34(5) :676 - 682.
  • 2Kar S, Carr BI. Growth inhibition and protein tyrosine phosphorylation in MCF 7 breast cancer cells by a novel K vitamin[J]. Cell Physiol,2000,185(3) :386 - 393.
  • 3Ni R, Nishikawa Y, Cart BI. Cell growth inhibition by a novel vitamin K is associated with induction of protein tyrosine phosphorylation [ J]. Biol Chem, 1998, 273 ( 16 ) : 9906-9911.
  • 4Enokimura N, Shiraki K, Kawakita T, et al. Vitamin K analog (compound 5) induces apoptosis in human hepatocellular carcinoma independent of the caspase pathway[J]. Anticancer Drugs, 2005,16(8) :837 - 844.
  • 5Han Y, Shen H, Carr BI, et al. NAD(P) H : quinone oxidoreductase-1-dependent and-independent cytotoxicity of potent quinone Cdc25 phosphatase inhibitors[ J]. Pharmacol Exp Ther,2004, 309(1) :64 - 70.
  • 6Osada S, Carr BI. Critical role of extraeellular signal-regulated kinase (ERK) phosphorylation in novel vitamin K analog-induced cell death[J]. Jpn J Cancer Res,2000,91 (12) : 1250 - 1257.
  • 7Osada S, Carr BI. Mechanism of novel vitamin K analog induced growth inhibition in human hepatoma cell line[J]. Hepatol, 2001,34 (5) : 676 - 682.
  • 8Chao JI, Kuo PC, Hsu TS, et al. Down-regulation of survivin in nitric oxide-induced cell growth inhibition and apoptosis of the human lung carcinoma cells[J]. Biol Chem, 2004, 279(19) :20267 - 20276.
  • 9Mizuno R, Oya M, Ham S, et al. Modulation of bcl-2 family proteins in MAPK independent apoptosis induced by a cdc25 phosphatase inhibitor Cpd 5 in renal cancer cells [J]. Oncol Rep, 2005,14(3) :639 - 644.
  • 10Wang Z, Zhang B, Wang M, et al. Cdc25A and ERK interaction: EGFR-independent ERK activation by a protein phosphatase Cdc25A inhibitor, compotmd 5 [ J ]. Cell Physiol, 2005, 204(2):437-444.

同被引文献17

  • 1Savarese A,Cognetti F. New drugs in the treatment of recurrent Or metastatic cervical cancer[J]. Crit Rev Oncol Hematol, 2003, 48(3) ;323-327.
  • 2Ni R,Nishikawa Y,Carr BI. Cell growth inhibition by a novel vi- tamin K is associated with induction of protein tyrosine phospho- rylation[,J]. Biol Chem, 1998,273(16) : 9906-9911.
  • 3Kar S,Carr BI. Growth inhibition and protein tyrosine phospho- rylation in MCF 7 breast cancer cells by a novel K vitamin[J]. Cell Physiol,2000,185(3) ..386-393.
  • 4Han Y, Shen H ,Cart BI, et al. NAD (P) H, quinone oxidoredue- tase-l-dependent and-independent cytotoxicity of potent quinone Cdc25 phosphatase inhibitors[J]. Pharmaeol Exp Ther, 2004, 309(1) ..64-70.
  • 5Osada S, Cart BI. Critical role of extracellular signal-regulated kinase (ERK) phosphorylation in novel vitamin K analog-in- duced cell death[J]. Jpn J Cancer Res,2000,91(12) :1250-1257.
  • 6Mizuno R,Oya M, Hara S,et al. Modulation of bel-2 family pro- teins in MAPK independent apoptosis induced by a edc25 phos- phatase inhibitor Cpd 5 in renal cancer cells[,J]. Oneol Rep, 2005,14(3) : 639-644.
  • 7Chao JI, Kuo PC, Hsu TS, et al. Down-regulation of survivin in nitric oxide-induced cell growth inhibition and apoptosis of the human lung carcinoma cells [J]. Biol Chem, 2004, 279 (19): 20267-20276.
  • 8王琳,刘新奎,师秀琴.Akt通路在热化疗联合诱导人小细胞肺癌细胞凋亡中的作用[J].癌症,2010,29(4):429-433. 被引量:8
  • 9赵婧,屈艺,母得志.Akt与细胞线粒体凋亡途径[J].生命的化学,2010,30(4):528-532. 被引量:21
  • 10冉芳,蒋江涛,赵虹,杨新惠,张波,王振华,郑秋生.紫草素通过氧化胁迫诱导K562细胞凋亡[J].中国实验方剂学杂志,2013,19(13):221-225. 被引量:7

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部